PGE2 displays immunosuppressive effects during human active tuberculosis
Open Access
- 30 June 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-14
Abstract
Prostaglandin E2 (PGE2), an active lipid compound derived from arachidonic acid, regulates different stages of the immune response of the host during several pathologies such as chronic infections or cancer. In fact, manipulation of PGE2 levels was proposed as an approach for countering the Type I IFN signature of tuberculosis (TB). However, very limited information regarding the PGE2 pathway in patients with active TB is currently available. In the present work, we demonstrated that PGE2 exerts a potent immunosuppressive action during the immune response of the human host againstMycobacterium tuberculosis (Mtb)infection. Actually, we showed that PGE2 significantly reduced the surface expression of several immunological receptors, the lymphoproliferation and the production of proinflammatory cytokines. In addition, PGE2 promoted autophagy in monocytes and neutrophils cultured withMtbantigens. These results suggest that PGE2 might be attenuating the excessive inflammatory immune response caused byMtb, emerging as an attractive therapeutic target. Taken together, our findings contribute to the knowledge of the role of PGE2 in the human host resistance toMtband highlight the potential of this lipid mediator as a tool to improve anti-TB treatment.Keywords
All Related Versions
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica (PICT-2015-0611)
- Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires (20020170100127BA)
This publication has 63 references indexed in Scilit:
- The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In VivoPLOS ONE, 2013
- Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammationProceedings of the National Academy of Sciences, 2012
- An Important Role of Prostanoid Receptor EP2 in Host Resistance to Mycobacterium tuberculosis Infection in MiceThe Journal of Infectious Diseases, 2012
- Regulation of Immune Responses by Prostaglandin E2The Journal of Immunology, 2012
- The Role of Nuclear Factor κB in the Interferon ResponseJournal of Interferon & Cytokine Research, 2011
- Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage populationJournal of Clinical Investigation, 2010
- Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repairNature Immunology, 2009
- Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage deathJournal of Experimental Medicine, 2008
- Mannose‐capped lipoarabinomannan‐ and prostaglandin E2‐dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infectionEuropean Journal of Immunology, 2008
- Cross‐Talk between CD31 and the Signaling Lymphocytic Activation Molecule–Associated Protein during Interferon‐γ Production againstMycobacterium tuberculosisThe Journal of Infectious Diseases, 2007